copper ghk cu GHK-Cu 100mg Cu peptide serum with 1% copper peptide for anti GHK-CU - 100mg (Copper Peptide)

Cagrilintide and retatrutide are two investigational peptide-based medicines currently being studied for the treatment of obesity and related metabolic conditions

the clinical relevance of this finding in humans is unknown, and in UK and EU prescribing information this is noted as a precaution rather than a formal contraindication but individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) should discuss this with their doctor

99%+ Purity Guarantee Research-grade peptides with verified potency

Light exposure also accelerates degradation, so store vials in a dark location or wrap them in aluminum foil